Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
BTCY

BTCY - Biotricity Inc. Stock Price, Fair Value and News

$0.30-0.01 (-3.23%)
Market Closed

73/100

BTCY

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

73/100

BTCY

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.41

Target 3M

$0.31

Target 6M

$0.34

BTCY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BTCY Price Action

Last 7 days

7.1%

Last 30 days

7.1%

Last 90 days

-45.4%

Trailing 12 Months

-21.0%

BTCY RSI Chart

BTCY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BTCY Valuation

Market Cap

8.3M

Price/Earnings (Trailing)

-1.84

Price/Sales (Trailing)

0.55

EV/EBITDA

-11.21

Price/Free Cashflow

-18.67

BTCY Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.41

Target 3M

$0.31

Target 6M

$0.34

BTCY Fundamentals

BTCY Revenue

Revenue (TTM)

15.1M

Rev. Growth (Yr)

18.95%

Rev. Growth (Qtr)

0.3%

BTCY Earnings

Earnings (TTM)

-4.5M

Earnings Growth (Yr)

55.76%

Earnings Growth (Qtr)

-2.82%

BTCY Profitability

Operating Margin

79.84%

EBT Margin

-30.02%

Return on Equity

13.55%

Return on Assets

-71.61%

Free Cashflow Yield

-5.36%

BTCY Investor Care

Shares Dilution (1Y)

13.95%

Diluted EPS (TTM)

-0.11

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202513.8M14.5M15.1M0
202412.1M12.2M12.6M13.3M
20239.6M10.6M11.1M11.6M
20227.7M7.9M8.5M9.0M
20213.4M4.7M5.8M6.7M
20201.4M1.5M1.9M2.6M
2019414.6K724.0K952.2K1.2M
20180000
Get all data in R, Python etc through our Historical Stock Data APIs

About Biotricity Inc.

BTCY
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
 CEO
 WEBSITEbiotricity.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES55

Biotricity Inc. Frequently Asked Questions

BTCY is the stock ticker symbol of Biotricity Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Biotricity Inc. is 8.34 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check BTCY's fair value in chart for subscribers.

The fair value guage provides a quick view whether BTCY is over valued or under valued. Whether Biotricity Inc. is cheap or expensive depends on the assumptions which impact Biotricity Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BTCY.

As of Wed Jan 28 2026, BTCY's PE ratio (Price to Earnings) is -1.84 and Price to Sales (PS) ratio is 0.55. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BTCY PE ratio will change depending on the future growth rate expectations of investors.